The Valley Desk

Clinical trial reportThe New England journal of medicinePublished

Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma

24 of 34 authors shown in byline order.

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Penn Medicine. Affiliation source

Institution
Penn Medicine

Publication record

Type
Clinical trial report
Venue
The New England journal of medicine
Published
Subject terms
Humans; Carcinoma, Renal Cell; Kidney Neoplasms; Adjuvants, Immunologic; Disease-Free Survival; Combined Modality Therapy; Survival Analysis; Double-Blind Method; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological
PubMed ID
38631003
Added to directory
Source checked

Report a correction or request removal